Diabetes drug for adults may help obese youths lose weight

02/4/2013 | Reuters

Severely obese youths who received exenatide injections twice a day for three months lost about 7 pounds more than the placebo group, according to a study in JAMA Pediatrics. Initially approved by the FDA for adults with type 2 diabetes, exenatide showed potential "in terms of weight reduction and cardiovascular risk control," lead author Aaron Kelly said.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA